Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Rätt läkemedel till rätt patient – ett paradigmskifte på väg

Ett nytt sätt att se på läkemedel mot cancer har gjort sitt intåg – läkemedel som förskrivs vid en viss genmutation istället för vid en viss cancersjukdom. Det ...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

Teams up with leading dermatologist

Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

How critical are the “Spermageddon” reports? – Researchers call for action

A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden s...

Pilots want to live too

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...

"Konsulter ger oss nya perspektiv"

Pernilla Sandwall, Chief Operating Officer på Index Pharmaceutcals, berättade på Life Science Swedens event Pharma Outsourcing om bolagets modell för outsourcing.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Sverige stöttar danskt initiativ om hormonstörande ämnen

En dansk myndighet har skapat ett webbplats där kunskap om hormonstörande ämnen ska samlas in. Flera EU-länder ansluter sig till initiativet.

Anna Törner: Never let me go – är vi redan där?

Vad kan tillåta oss inom modern genteknologi, och vad exakt är det som gör vissa tankar oacceptabla? Anna Törner skriver i sin krönika om en tankeväckande dysto...

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

How to get visitors to your booth

Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.

Fusion att vänta

Oncology Venture och Medical Prognosis Institute planerar fusion av bolagen. Vill skapa "one stop shop".

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...